This month's roundup of the latest industry products.
VA patients with cannabis use disorder increased 10 percent over 12 years
Improving patient satisfaction with a personalized approach
RSNA releases details on Gadolinium-based magnetic resonance imaging (MRI) contrast agents; may be dangerous to patients with advanced kidney disease.
Usage declined in 2009 but spiked in 2011
Claims to lower dose by 30 percent.
Dr. Steven Mendelsohn, Chief Executive Officer/Medical Director of Zwanger-Pesiri Radiology, New York, explains his commitment to dose reduction and why he believes a change in attitudes will be driven by patients rather than radiology professionals.
Group maintains that most women should wait until 50 for regular screening
Paving the way for a more intelligent care continuum
Discussing the challenges and opportunities on the horizon
Sharper images and no increase in dose
Alarm hazards top the list again.
